Kelly Schwartz

953 total citations
8 papers, 674 citations indexed

About

Kelly Schwartz is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Psychiatry and Mental health. According to data from OpenAlex, Kelly Schwartz has authored 8 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Experimental and Cognitive Psychology and 3 papers in Psychiatry and Mental health. Recurrent topics in Kelly Schwartz's work include Treatment of Major Depression (5 papers), Schizophrenia research and treatment (3 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers). Kelly Schwartz is often cited by papers focused on Treatment of Major Depression (5 papers), Schizophrenia research and treatment (3 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers). Kelly Schwartz collaborates with scholars based in United States. Kelly Schwartz's co-authors include Russell L. Kolts, Arif Khan, Kenneth Alper, Arif Khan, Walter A. Brown, Charles G. Lineberry, Derry Ridgway and Donald S. Robinson and has published in prestigious journals such as Biological Psychiatry, Neuropsychopharmacology and Journal of Affective Disorders.

In The Last Decade

Kelly Schwartz

8 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kelly Schwartz United States	8	324	172	158	124	89	8	674
Tatjana Dose Germany	7	174 0.5×	196 1.1×	109 0.7×	83 0.7×	65 0.7×	10	658
Ballenger Jc United States	15	327 1.0×	109 0.6×	129 0.8×	128 1.0×	135 1.5×	19	650
Teresa Huggins United States	10	332 1.0×	122 0.7×	54 0.3×	90 0.7×	49 0.6×	13	619
Christopher Silber United States	9	369 1.1×	156 0.9×	71 0.4×	127 1.0×	31 0.3×	26	726
Katherine Tracy United States	15	649 2.0×	180 1.0×	216 1.4×	183 1.5×	48 0.5×	19	1.0k
P. J. Perry United States	12	526 1.6×	216 1.3×	66 0.4×	138 1.1×	97 1.1×	20	872
Elisse Kramer United States	16	238 0.7×	204 1.2×	54 0.3×	187 1.5×	68 0.8×	26	891
M.Dhyanne Warner United States	14	296 0.9×	84 0.5×	82 0.5×	64 0.5×	90 1.0×	34	741
Jeffrey S. Simon United States	11	355 1.1×	380 2.2×	49 0.3×	99 0.8×	122 1.4×	13	875
Thomas Walch Austria	14	406 1.3×	83 0.5×	66 0.4×	57 0.5×	37 0.4×	15	781

Countries citing papers authored by Kelly Schwartz

Since Specialization

Citations

This map shows the geographic impact of Kelly Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Schwartz more than expected).

Fields of papers citing papers by Kelly Schwartz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Schwartz. The network helps show where Kelly Schwartz may publish in the future.

Co-authorship network of co-authors of Kelly Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Schwartz. A scholar is included among the top collaborators of Kelly Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Schwartz. Kelly Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Alper, Kenneth, Kelly Schwartz, Russell L. Kolts, & Arif Khan. (2007). Seizure Incidence in Psychopharmacological Clinical Trials: An Analysis of Food and Drug Administration (FDA) Summary Basis of Approval Reports. Biological Psychiatry. 62(4). 345–354. 325 indexed citations

2.

Khan, Arif & Kelly Schwartz. (2007). Suicide Risk and Symptom Reduction in Patients Assigned to Placebo in Duloxetine and Escitalopram Clinical Trials: Analysis of the FDA Summary Basis of Approval Reports. Annals of Clinical Psychiatry. 19(1). 31–36. 12 indexed citations

3.

Khan, Arif, et al.. (2007). Mortality Risk in Patients With Schizophrenia Participating in Premarketing Atypical Antipsychotic Clinical Trials. The Journal of Clinical Psychiatry. 68(12). 1828–1833. 13 indexed citations

4.

Khan, Arif, et al.. (2007). Psychiatric Diagnosis and Clinical Trial Completion Rates: Analysis of the FDA SBA Reports. Neuropsychopharmacology. 32(11). 2422–2430. 15 indexed citations

5.

Khan, Arif, Kelly Schwartz, Russell L. Kolts, Derry Ridgway, & Charles G. Lineberry. (2006). Relationship Between Depression Severity Entry Criteria and Antidepressant Clinical Trial Outcomes. Biological Psychiatry. 62(1). 65–71. 39 indexed citations

6.

Khan, Arif, Kelly Schwartz, Russell L. Kolts, & Walter A. Brown. (2006). BMI, sex, and antidepressant response. Journal of Affective Disorders. 99(1-3). 101–106. 50 indexed citations

7.

Khan, Arif, et al.. (2005). Sex Differences in Antidepressant Response in Recent Antidepressant Clinical Trials. Journal of Clinical Psychopharmacology. 25(4). 318–324. 187 indexed citations

8.

Khan, Arif & Kelly Schwartz. (2005). Study designs and outcomes in antidepressant clinical trials.. PubMed. 6(4). 221–6. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact